Publications by authors named "E L Buck"
Anhydrous plutonium tetrafluoride is an important intermediate in the production of metallic Pu. This historically important compound is also known to exist in at least two distinct, yet understudied hydrate forms, PuF·HO(s) (0.5 ≤ ≤ 2) and PuF·2.
View Article and Find Full Text PDFOncogenic mutations in the extracellular domain (ECD) of cell-surface receptors could serve as tumor-specific antigens that are accessible to antibody therapeutics. Such mutations have been identified in receptor tyrosine kinases including HER2. However, it is challenging to selectively target a point mutant, while sparing the wild-type protein.
View Article and Find Full Text PDFArticle Synopsis
- The highly pathogenic H5 clade 2.3.4.4b avian influenza (HPAI) outbreak reached North America in late 2021 and was first detected in Alaska in April 2022.
- Researchers analyzed 177 HPAI virus genomes collected in Alaska from April to December 2022, revealing multiple introductions of the virus into the state during this period.
- The study highlighted how HPAI spread among various species, including wild birds and domestic poultry, and stressed the importance of ongoing monitoring and genomic analysis for better understanding and response to this virus.
Most plasma used for manufacturing plasma-derived medicinal products (PDMPs) such as albumin, immunoglobulin (Ig), and clotting factors is obtained from source plasma collected via plasmapheresis, the majority of which is contributed by the United States (US). While the demand for PDMPs continues to rise, it remains unclear whether high-frequency plasmapheresis, such as the twice-weekly plasma donation allowed in the US, may have any (long-term) adverse health effects on the donor. To investigate the frequency at which plasma can be donated without harm to the donor, the current systematic review explores the impact of plasma donation frequency on cardiovascular health, protein depletion, and adverse events in healthy plasma donors.
View Article and Find Full Text PDFBackground And Objectives: Blood establishments strive to ensure the safety and comfort of blood donors while minimizing adverse events. This review aims to assess the efficacy and effectiveness of eating and/or drinking interventions before, during and/or after blood donation in reducing vasovagal reactions (VVRs).
Materials And Methods: We analysed randomized and non-randomized controlled trials comparing eating and/or drinking interventions to no intervention, placebo or usual practice on (pre-)syncopal VVRs and related symptoms.